表紙:薬物スクリーニングの世界市場(2022年~2028年):製品・サービス別、最終用途別、地域別の市場規模調査と予測
市場調査レポート
商品コード
1073728

薬物スクリーニングの世界市場(2022年~2028年):製品・サービス別、最終用途別、地域別の市場規模調査と予測

Global Drug Screening Market Size study, by Product and Service, by End-Use and Regional Forecasts 2022-2028

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
薬物スクリーニングの世界市場(2022年~2028年):製品・サービス別、最終用途別、地域別の市場規模調査と予測
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬物スクリーニングの市場規模は、2021年に約54億米ドルとなり、2022年~2028年の予測期間中に17.00%以上の健全な成長率で成長すると予想されています。市場を牽引する主な要因には、薬物とアルコールの消費量の増加、薬物とアルコールの検査を義務付ける厳しい法律の施行などがあります。しかし、アルコール摂取の禁止や政府の規制が、予測期間における市場の成長を阻害しています。

当レポートでは世界の薬物スクリーニング市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の薬物スクリーニング市場:定義と範囲

第3章 世界の薬物スクリーニング:市場力学

  • 薬物スクリーニング市場:影響分析(2020年~2028年)

第4章 世界の薬物スクリーニング市場:業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価:COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前とCOVID-19後の市場シナリオ

第6章 世界の薬物スクリーニング市場:製品・サービス別

  • 市場のスナップショット
  • 実績:潜在的な分析
  • 市場規模の推計と予測(2019年~2028年)
  • サブセグメント分析
    • 薬物スクリーニング製品
    • 分析機器
    • 迅速検査装置
    • 口腔液検査装置
    • 消耗品

第7章 世界の薬物スクリーニング市場:最終用途別

  • 市場のスナップショット
  • 実績:潜在的な分析
  • 市場規模の推計と予測(2019年~2028年)
  • サブセグメント分析
    • 薬物検査研究所
    • 職場
    • 刑事司法と法執行機関
    • 病院
    • 薬物治療センター
    • 個人利用者
    • 疼痛管理センター
    • 学校と大学

第8章 世界の薬物スクリーニング市場:地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Dragerwerk(ドイツ)
    • LabCorp(米国)
    • Quest Diagnostics(米国)
    • Abbott Laboratories(米国)
    • Thermo Fisher Scientific, Inc.(米国)
    • Alfa Scientific Designs, Inc.(米国)
    • OraSure Technologies, Inc.(米国)
    • Siemens Healthineers(ドイツ)
    • Roche(スイス)
    • MPD Inc.(米国)
    • Shimadzu(日本)

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Drug Screening market, report scope
  • TABLE 2. Global Drug Screening market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Drug Screening market estimates & forecasts by Product and Service 2019-2028 (USD Billion)
  • TABLE 4. Global Drug Screening market estimates & forecasts by End-Use 2019-2028 (USD Billion)
  • TABLE 5. Global Drug Screening market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 6. Global Drug Screening market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Drug Screening market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Drug Screening market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Drug Screening market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Drug Screening market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Drug Screening market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Drug Screening market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Drug Screening market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Drug Screening market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. U.S. Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 17. U.S. Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. Canada Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 19. Canada Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 20. Canada Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. UK Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 22. UK Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 23. UK Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. Germany Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 25. Germany Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 26. Germany Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. RoE Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 28. RoE Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 29. RoE Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. China Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 31. China Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 32. China Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. India Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 34. India Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 35. India Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. Japan Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 37. Japan Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 38. Japan Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. RoAPAC Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. Brazil Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 43. Brazil Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 44. Brazil Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Mexico Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 46. Mexico Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 47. Mexico Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. RoLA Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 49. RoLA Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 50. RoLA Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. Row Drug Screening market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 52. Row Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 53. Row Drug Screening market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Drug Screening market
  • TABLE 55. List of primary sources, used in the study of global Drug Screening market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Drug Screening market, research methodology
  • FIG 2. Global Drug Screening market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Drug Screening market, key trends 2021
  • FIG 5. Global Drug Screening market, growth prospects 2022-2028
  • FIG 6. Global Drug Screening market, porters 5 force model
  • FIG 7. Global Drug Screening market, pest analysis
  • FIG 8. Global Drug Screening market, value chain analysis
  • FIG 9. Global Drug Screening market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Drug Screening market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Drug Screening market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Drug Screening market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Drug Screening market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Drug Screening market, regional snapshot 2019 & 2028
  • FIG 15. North America Drug Screening market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Drug Screening market 2019 & 2028 (USD Billion)
  • FIG 17. Asia pacific Drug Screening market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Drug Screening market 2019 & 2028 (USD Billion)
  • FIG 19. Global Drug Screening market, company market share analysis (2021)
目次

Global Drug Screening Market is valued at approximately USD 5.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 17.00 % over the forecast period 2022-2028. Drug screening is the process by which potential drugs are identified and optimized before the selection of a candidate drug to progress to clinical trials. The growing drug and alcohol consumption and enforcement of stringent laws mandating drug & alcohol testing have led to the adoption of Drug Screening across the forecast period. For Instance: According to the World Drug Report 2021, in 2019, an estimated 275 million people worldwide aged 15-64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year (range: 175 million to 374 million. In 2019, 36.3 million people, or almost 13% of the global population, were estimated to be suffering from drug use disorders. Also, with the oral fluid testing and emerging economies, the adoption & demand for Drug Screening is likely to increase the market growth during the forecast period. However, ban on alcohol consumption and government regulations impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Drug Screening Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing consumption of illicit drugs, the availability of government funding to curb drug abuse. Whereas, Europe is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as laws supporting drug screening, the growing burden of accidents due to alcohol impairment, and the presence of key players in the region would create lucrative growth prospects for the Drug Screening Market across Europe region.

Major market players included in this report are:

Dragerwerk (Germany)

LabCorp (US)

Quest Diagnostics (US)

Abbott Laboratories (US)

Thermo Fisher Scientific, Inc. (US)

Alfa Scientific Designs, Inc. (US)

OraSure Technologies, Inc. (US)

Siemens Healthineers (Germany)

Roche (Switzerland)

MPD Inc. (US)

Shimadzu (Japan)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product and Service:

Drug Screening Product

Analytical Instruments

Rapid Testing Devices

Oral Fluid Testing Devices

Consumables

By End-Use:

Drug Testing Laboratories

Workplaces

Criminal Justice and Law Enforcement Agencies

Hospitals

Drug Treatment Centers

Individual Users

Pain Management Centers

Schools and Colleges

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Drug Screening Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Drug Screening Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Drug Screening Market, by Product and Service, 2020-2028 (USD Billion)
    • 1.2.3. Drug Screening Market, by End-Use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Screening Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Screening Market Dynamics

  • 3.1. Drug Screening Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing drug and alcohol consumption
      • 3.1.1.2. Enforcement of stringent laws mandating drug & alcohol testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Ban on alcohol consumption
      • 3.1.2.2. Government regulations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Oral fluid testing
      • 3.1.3.2. Emerging economies

Chapter 4. Global Drug Screening Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Drug Screening Market, by Product and Service

  • 6.1. Market Snapshot
  • 6.2. Global Drug Screening Market by Product and Service, Performance - Potential Analysis
  • 6.3. Global Drug Screening Market Estimates & Forecasts by Product and Service, 2019-2028 (USD Billion)
  • 6.4. Drug Screening Market, Sub Segment Analysis
    • 6.4.1. Drug Screening Product
    • 6.4.2. Analytical Instruments
    • 6.4.3. Rapid Testing Devices
    • 6.4.4. Oral Fluid Testing Devices
    • 6.4.5. Consumables

Chapter 7. Global Drug Screening Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Global Drug Screening Market by End-Use, Performance - Potential Analysis
  • 7.3. Global Drug Screening Market Estimates & Forecasts by End-Use, 2019-2028 (USD Billion)
  • 7.4. Drug Screening Market, Sub Segment Analysis
    • 7.4.1. Drug Testing Laboratories
    • 7.4.2. Workplaces
    • 7.4.3. Criminal Justice and Law Enforcement Agencies
    • 7.4.4. Hospitals
    • 7.4.5. Drug Treatment Centers
    • 7.4.6. Individual Users
    • 7.4.7. Pain Management Centers
    • 7.4.8. Schools and Colleges

Chapter 8. Global Drug Screening Market, Regional Analysis

  • 8.1. Drug Screening Market, Regional Market Snapshot
  • 8.2. North America Drug Screening Market
    • 8.2.1. U.S. Drug Screening Market
      • 8.2.1.1. Product and Service breakdown estimates & forecasts, 2019-2028
      • 8.2.1.2. End-Use breakdown estimates & forecasts, 2019-2028
    • 8.2.2. Canada Drug Screening Market
  • 8.3. Europe Drug Screening Market Snapshot
    • 8.3.1. U.K. Drug Screening Market
    • 8.3.2. Germany Drug Screening Market
    • 8.3.3. France Drug Screening Market
    • 8.3.4. Spain Drug Screening Market
    • 8.3.5. Italy Drug Screening Market
    • 8.3.6. Rest of Europe Drug Screening Market
  • 8.4. Asia-Pacific Drug Screening Market Snapshot
    • 8.4.1. China Drug Screening Market
    • 8.4.2. India Drug Screening Market
    • 8.4.3. Japan Drug Screening Market
    • 8.4.4. Australia Drug Screening Market
    • 8.4.5. South Korea Drug Screening Market
    • 8.4.6. Rest of Asia Pacific Drug Screening Market
  • 8.5. Latin America Drug Screening Market Snapshot
    • 8.5.1. Brazil Drug Screening Market
    • 8.5.2. Mexico Drug Screening Market
  • 8.6. Rest of The World Drug Screening Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Dragerwerk (Germany)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. LabCorp (US)
    • 9.2.3. Quest Diagnostics (US)
    • 9.2.4. Abbott Laboratories (US)
    • 9.2.5. Thermo Fisher Scientific, Inc. (US)
    • 9.2.6. Alfa Scientific Designs, Inc. (US)
    • 9.2.7. OraSure Technologies, Inc. (US)
    • 9.2.8. Siemens Healthineers (Germany)
    • 9.2.9. Roche (Switzerland)
    • 9.2.10. MPD Inc. (US)
    • 9.2.11. Shimadzu (Japan)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption